Related Experiment Video
Updated: Mar 16, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Local Recurrence of Extremity Soft Tissue Sarcoma.
Whitney M Guerrero1, Jeremiah L Deneve2
1Department of Surgery, University of Tennessee Health Science Center, 910 Madison Ave, Suite 300, Memphis, TN 38163, USA.
The Surgical Clinics of North America
|August 21, 2016
Summary
Managing recurrent soft tissue sarcoma is complex, impacting patients physically and mentally. This review focuses on treatment strategies for recurrent extremity soft tissue sarcoma, a common challenge.
Area of Science:
- Oncology
- Surgical Oncology
- Medical Oncology
Background:
- Recurrent soft tissue sarcoma presents a significant clinical challenge.
- Approximately 25% of patients experience disease recurrence despite limb-preservation therapies.
- The management of recurrent disease significantly impacts patient's physical, mental, and emotional well-being.
Purpose of the Study:
- To highlight current management strategies for recurrent extremity soft tissue sarcoma.
- To provide an overview of treatment options for patients with recurrent soft tissue sarcoma.
- To address the debate surrounding the optimal management of recurrent soft tissue sarcoma.
Main Methods:
- Review of existing literature on recurrent soft tissue sarcoma management.
- Discussion of various treatment modalities including surgery, radiation, chemotherapy, and regional therapies.
- Focus on extremity soft tissue sarcoma recurrence.
Main Results:
- Multiple treatment options are available for recurrent soft tissue sarcoma.
- Surgical resection, irradiation, chemotherapy, amputation, and regional therapies are discussed.
- Limb-preservation therapies are effective but recurrence remains a concern.
Conclusions:
- The management of recurrent soft tissue sarcoma requires careful consideration of multiple factors.
- Optimal treatment strategies for recurrent extremity soft tissue sarcoma are debated.
- Further research may clarify the best approaches for managing recurrent soft tissue sarcoma.

